1. Home
  2. MRVI vs NBB Comparison

MRVI vs NBB Comparison

Compare MRVI & NBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$4.82

Market Cap

559.0M

Sector

Health Care

ML Signal

HOLD

Logo Nuveen Taxable Municipal Income Fund of Beneficial Interest

NBB

Nuveen Taxable Municipal Income Fund of Beneficial Interest

HOLD

Current Price

$15.78

Market Cap

465.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRVI
NBB
Founded
2014
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
559.0M
465.9M
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
MRVI
NBB
Price
$4.82
$15.78
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$4.13
N/A
AVG Volume (30 Days)
2.6M
47.2K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
14.29
N/A
EPS
N/A
N/A
Revenue
$185,743,000.00
N/A
Revenue This Year
$12.54
N/A
Revenue Next Year
$7.87
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.99
$14.95
52 Week High
$5.00
$16.62

Technical Indicators

Market Signals
Indicator
MRVI
NBB
Relative Strength Index (RSI) 68.22 51.66
Support Level $3.27 $15.51
Resistance Level $5.00 $16.05
Average True Range (ATR) 0.25 0.23
MACD 0.01 0.01
Stochastic Oscillator 81.91 66.13

Price Performance

Historical Comparison
MRVI
NBB

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

About NBB Nuveen Taxable Municipal Income Fund of Beneficial Interest

Nuveen Taxable Municipal Income Fund is a closed-end fund incorporated in the United States. Its primary objective is current income through investments in taxable municipal securities; the secondary objective is to seek enhanced portfolio value and total return. The fund invests a majority of its assets in a diversified portfolio of taxable municipal securities.

Share on Social Networks: